ABFM Practice Exam 2025 – Comprehensive Prep Resource

Focusing on the treatment of external genital warts during pregnancy, it is crucial to acknowledge that certain treatments can pose risks to fetal development. Many common treatments employed for genital warts are contraindicated during pregnancy due to the potential for causing fetal harm. For instance, some topical medications that are effective in treating warts may have teratogenic effects, meaning they could disrupt fetal growth or development when absorbed transdermally.

Moreover, since pregnancy leads to physiological changes, health care providers typically adopt a cautious approach and may recommend observation rather than aggressive treatment to limit any risk to the fetus. While the presence of warts can be distressing, the safety of both the mother and baby is paramount when considering management options. It's also essential for providers to stay informed about which treatments are safe or unsafe during pregnancy to ensure the well-being of their patients and their unborn children.